Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$897,126,545
+$190,213,144 QoQ
Shares Held
3,565,119
+9.7% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#55
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $4,134,092,265 across 9 Drug Manufacturers - General names. ABBV ranks #2 (21.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
758,740 | $910,055,594 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
3,565,119 | $897,126,545 | |
| 3 | JNJ |
Johnson & Johnson
|
1,966,109 | $499,332,702 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,459,893 | $437,122,881 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
7,244,630 | $417,435,580 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,373,993 | $305,058,100 | |
| 7 | PFE |
Pfizer Inc
|
11,918,197 | $286,990,183 | |
| 8 | AMGN |
Amgen Inc
|
580,049 | $210,047,343 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $897,126,545 | 3,565,119 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $706,913,401 | 3,250,326 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $733,485,117 | 3,210,141 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $769,415,755 | 3,323,036 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $587,051,649 | 3,162,653 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $812,252,888 | 3,876,732 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $653,701,969 | 3,678,683 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $704,165,889 | 3,565,758 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $566,606,371 | 3,303,442 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $596,212,881 | 3,274,096 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $336,750,894 | 2,173,007 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $228,403,147 | 1,532,290 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $203,705,966 | 1,511,957 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $238,915,551 | 1,499,125 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $277,608,324 | 1,717,767 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $275,697,537 | 2,054,225 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $340,923,898 | 2,225,933 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $313,978,700 | 1,936,825 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $142,137,639 | 1,049,761 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $80,070,714 | 742,289 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $83,536,527 | 741,624 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $166,439,329 | 1,537,972 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $205,232,216 | 1,915,373 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $244,977,054 | 2,796,861 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $276,909,719 | 2,820,429 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $210,071,982 | 2,757,212 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||